affinity_maturation

Antibody affinity defines binding strength. Biointron explains its role in potency, therapeutic success, and the development of optimized antibodies.

Engineering CDR loops boosts binding strength. Biointron outlines strategies to optimize CDRs for developing potent therapeutic antibodies.

Somatic hypermutation drives high-affinity antibodies. Biointron explains its role in B cell evolution and therapeutic antibody optimization.

DOI:10.1126/science.adg0564 B cells, or B lymphocytes, are a crucial component of the adaptive immune system andhumoral immunity. They originate from the bone marrow and mature in secondary lymphoid organs, such as the spleen and lymph nodes. The B ce

Understand affinity maturation from natural immune processes to Biointron’s FCMES-AM™ platform, enhancing antibody affinity, specificity, and therapeutic performance.

Learn how antibody optimization techniques like humanization, deimmunization, affinity maturation & Fc engineering improve therapeutic antibodies.